Gene: COL4A6
Official Full Name: collagen type IV alpha 6 chainprovided by HGNC
Gene Summary: This gene encodes one of the six subunits of type IV collagen, the major structural component of basement membranes. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene, alpha 5 type IV collagen, so that the gene pair shares a common promoter. Deletions in the alpha 5 gene that extend into the alpha 6 gene result in diffuse leiomyomatosis accompanying the X-linked Alport syndrome caused by the deletion in the alpha 5 gene. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2013]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO01324 | COL4A6 Knockout cell line (HeLa) | Human | COL4A6 | 1:3~1:6 | Negative | Online Inquiry |
KO10402 | COL4A6 Knockout cell line (HCT 116) | Human | COL4A6 | 1:2~1:4 | Negative | Online Inquiry |
KO10403 | COL4A6 Knockout cell line (HEK293) | Human | COL4A6 | 1:3~1:6 | Negative | Online Inquiry |
KO10404 | COL4A6 Knockout cell line (A549) | Human | COL4A6 | 1:3~1:4 | Negative | Online Inquiry |
COL4A6 Gene Knockout Cell Lines are specialized cell lines that have been genetically modified to lack the expression of the collagen type IV alpha 6 chain (COL4A6) gene. This gene plays a pivotal role in the assembly of basement membranes, providing structural support to various tissues, particularly in the glomeruli of kidneys and the retina. The deletion of COL4A6 enables researchers to explore the functional consequences of this gene loss, simulating conditions that relate to certain genetic disorders and angiogenesis-related diseases.
The mechanisms through which these knockout cell lines function facilitate in-depth studies of COL4A6's involvement in cellular adhesion, migration, and signaling pathways. By disrupting the normal expression of COL4A6, these cell lines allow researchers to model and investigate disease mechanisms, particularly those associated with kidney pathology or developmental anomalies. The utility of these cell lines extends to drug testing, regenerative medicine, and gene therapy applications, making them a valuable resource for both basic and translational research.
One of the significant advantages of using COL4A6 Gene Knockout Cell Lines lies in their specificity and reproducibility for experiments targeting basement membrane dynamics. Unlike alternative models, which may introduce confounding factors or fail to accurately reproduce in vivo conditions, these knockout lines offer a clearer insight into gene function and disease pathways. This specificity enhances the validity of research findings while encouraging innovative approaches to the treatment of diseases such as nephrotic syndrome and retinopathy.
For researchers and clinicians, the value of COL4A6 Gene Knockout Cell Lines is paramount; they offer a robust platform for elucidating the role of COL4A6 in health and disease, ultimately contributing to the development of novel therapeutic strategies. Backed by our company's extensive expertise in genetic engineering and cell biology, we provide high-quality, validated knockout cell lines tailored to advance scientific discovery and clinical application.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.